Study of Long-term Peg Intron vs. Colchicine in Non-responders.
Status:
Completed
Trial end date:
2010-03-03
Target enrollment:
Participant gender:
Summary
In this study Peg-Intron will be tested to see if it will give better results than
Colchicine. At this time, there is currently no recommended maintenance treatment for
patients who have failed to respond to Interferon/Rebetron/Peg Intron and have advanced
fibrosis. The purpose of this study is to compare two treatments to slow down the progression
of liver disease and to prevent liver failure and liver cancer. The treatment will not cure
Hepatitis C, but is being evaluated to see if it can slow down disease progression.